B of A Securities Maintains Buy on Elevance Health, Raises Price Target to $646

Benzinga · 06/04/2024 12:29
B of A Securities analyst Kevin Fischbeck maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $621 to $646.